MedCap AB (61MA) Financial Statements
MedCap AB Financial Overview
MedCap AB's market cap is currently $760.84M. The company's EPS TTM is $18.28; its P/E ratio is 30.25; MedCap AB is estimated to report earnings on February 5, 2027, and the estimated EPS forecast is $0.51. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.11B | $ 1.81B | $ 1.59B | $ 1.11B | $ 916.30M |
| Gross Profit | $ 321.00M | $ 1.06B | $ 926.40M | $ 462.40M | $ 369.80M |
| Operating Income | $ 300.20M | $ 272.30M | $ 227.50M | $ 170.90M | $ 127.00M |
| EBITDA | $ 473.80M | $ 396.00M | $ 341.90M | $ 256.20M | $ 201.90M |
| Net Income | $ 219.80M | $ 207.40M | $ 172.20M | $ 117.60M | $ 96.50M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 370.40M | $ 370.10M | $ 188.20M | $ 236.20M | $ 139.70M |
| Total Assets | $ 2.61B | $ 1.99B | $ 1.66B | $ 1.43B | $ 1.17B |
| Total Debt | $ 482.90M | $ 358.00M | $ 261.20M | $ 340.00M | $ 256.90M |
| Net Debt | $ 112.50M | $ -12.10M | $ 73.00M | $ 103.80M | $ 117.20M |
| Total Liabilities | $ 1.15B | $ 703.20M | $ 635.10M | $ 570.60M | $ 471.80M |
| Stockholders' Equity | $ 1.45B | $ 1.28B | $ 1.02B | $ 856.30M | $ 696.00M |
| Cash Flow | |||||
| Free Cash Flow | $ 280.50M | $ 293.80M | $ 188.70M | $ 41.20M | $ 55.40M |
| Operating Cash Flow | $ 342.70M | $ 360.00M | $ 228.00M | $ 85.50M | $ 116.30M |
| Investing Cash Flow | $ -391.30M | $ -128.80M | $ -152.30M | $ -56.10M | $ -64.80M |
| Financing Cash Flow | $ 52.20M | $ -46.10M | $ -119.70M | $ 61.20M | $ -64.10M |
Currency in SEK
